People: Achillion Pharmaceuticals Inc (ACHN.O)
7.58USD
24 May 2013
$-0.06 (-0.79%)
$7.64
$7.63
$7.67
$7.40
482,454
1,022,199
$11.36
$5.42
Frashier, Gary
Brief Biography
Mr. Gary E. Frashier serves as Independent Director of Achillion Pharmaceuticals, Inc., since March 2008. He currently serves as chair of the company's Compensation Committee and as a member of the company's Nominating and Corporate Governance Committee. Mr. Frashier, through his company Management Associates, has been a strategic consultant to emerging growth companies in the life sciences field since 2000. From 1990 until September 1998, he served as Chief Executive Officer of OSI Pharmaceuticals, Inc., a biotechnology company, and from January 1997 until September 2000, as its Chairman of the Board. From 1987 until 1990, he served as President and CEO of Genex Corporation, a protein engineering company, and from 1984 until 1987, as Chairman and CEO of Continental Water Systems, Inc., a manufacturer and marketer of equipment to produce high purity water used by the pharmaceutical, medical, electronics and research industries. Mr. Frashier also served as Executive Vice President of Millipore Corporation, a provider of products and services to biopharmaceutical, manufacturing, clinical, analytical and research laboratories, and as President of Millipore’s Waters Associates subsidiary.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
David Scheer |
-- |
Michael Kishbauch |
1,422,900 |
Mary Fenton |
817,637 |
Gautam Shah |
827,612 |
Joseph Truitt |
976,868 |
Milind Deshpande |
1,067,720 |

